Showing results (51-60 of 128) with videos related to
Sort By:
Pageof 13
Leukemia Research|April 14, 2015
MicroRNA signature is indicative of long term prognosis in diffuse large B-cell lymphomaDaniel Shepshelovich, Ron Ram, Orit Uziel, et al.Harefuah|April 15, 2024
[CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T CELLS) THERAPY FOR B-CELL HEMATOLOGICAL MALIGNANCIES - FROM THE ISRAELI SOCIETY OF HEMATOLOGY AND TRANSFUSION MEDICINE]Uri Greenbaum, Dana Yehudai-Ofir, Ofrat Beyar Katz, et al.Annals of Hematology|November 28, 2017
Toxicity and efficacy of autologous hematopoietic cell transplantation in elderly patients with aggressive lymphoma: a historical prospective studyMarina Davidov, Chava Perry, Yair Herishanu, et al.International Journal of Antimicrobial Agents|June 26, 2012
Characteristics of initial compared with subsequent bacterial infections among hospitalised haemato-oncological patientsRon Ram, Laura Farbman, Leonard Leibovici, et al.Hematological Oncology|February 18, 2015
High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia--is more better or more of the same?Ofir Wolach, Gilad Itchaki, Michal Bar-Natan, et al.Haematologica|August 10, 2012
Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysisRonit Gurion, Anat Gafter-Gvili, Liat Vidal, et al.Clinical Lymphoma, Myeloma & Leukemia|May 19, 2018
Real-life Experience With Ponatinib in Chronic Myeloid Leukemia: A Multicenter Observational StudyAdi Shacham-Abulafia, Pia Raanani, David Lavie, et al.Leukemia Research|July 16, 2013
The role of ¹⁸F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropeniaAnat Gafter-Gvili, Mical Paul, Hanna Bernstine, et al.American Journal of Hematology|July 16, 2011
High-dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients--systematic review and meta-analysisAnat Gafter-Gvili, Avi Leader, Ronit Gurion, et al.Cancers|December 9, 2023
The Clinical Significance of Circulating Lymphocytes Morphology in Diffuse Large B-Cell Lymphoma As Determined by a Novel, Highly Sensitive MicroscopyGil Fridberg, Galit Horn, Anat Globerson Levin, et al.Pageof 13